NewsRoom Articles - Page 113 of 154 - PsychedelicNewsWire (PNW)

ThursdayDec 03, 2020 10:30 am

Could Psychedelics Be the Drugs That Bridge the Peace Gap?

For the first time, Israel treated patients who suffered from post-traumatic stress disorder with MDMA-assisted psychotherapy in February of this year. This was part of the Phase 3 trials of MDMA, which are a part of a research initiative being carried out in collaboration with the Multidisciplinary Association for Psychedelic Studies (“MAPS”), which is based in the United States. This initiative encompasses 15 sites in Israel, Canada and the U.S. and is expected to end in the last quarter of next year. The body anticipates that it will receive full regulatory approval from the FDA. The first trial that was…

WednesdayDec 02, 2020 3:15 pm

Advocates Set in Motion Efforts to Legalize Psychedelics in Washington State

Marijuana reform advocates in Oregon had separate measures on the ballot that called for the legalization of psilocybin mushrooms for therapeutic use and the decriminalization of the possession of all drugs on election day. Both ballot measures were approved, which may have inspired advocates in nearby Washington State to set their sights on similar reforms. Two measures were recently announced in the state: one aimed at legalizing mushrooms to be used in therapy as well as decriminalizing drug possession on a small scale in 2022, and the second pursues the expansion of the administrative measures already in place into psilocybin…

WednesdayDec 02, 2020 10:00 am

Pure Extracts Technologies Corp. (CSE: PULL) Issues Corporate Update Detailing Operations, Product Strategy and Market Conditions

Pure Extracts is a plant-based extraction company located in British Columbia, Canada that focuses on cannabis, hemp, functional mushrooms Pure Extracts’ “Pure Pulls” and “Pure Mushrooms’” branded products expected to be available by end of Q1 2021 Global cannabis extract market size expected to reach USD$28.5 billion by 2027 with CAGR of 16.6%; global functional mushrooms market expected to reach USD$34.3 billion by 2024 with CAGR of 8% Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and functional mushrooms, recently released a corporate update for shareholders and interested investors that provides current information on the…

TuesdayDec 01, 2020 3:00 pm

Psychedelics May Be Answer to Chronic Pain Relief

The U.S. election results revealed the increasing acceptance of cannabis, as voters in various states confirmed widespread desire to legalize the substance for recreational use. We also saw the authorization of the therapeutic use and psilocybin study in Oregon as well as its decriminalization in the District of Columbia. A lot of research has been done on the use of psychedelics to treat various mental health disorders. MDMA, which is commonly known as ecstasy and psilocybin, are currently in phase 3 studies for treatment of PTSD and depression. However, little research has been carried out that focuses on the use…

MondayNov 30, 2020 1:20 pm

Emerging Functional Mushroom Market Ripe with Potential for Rritual Superfoods’ New Product Line

Rritual Superfoods, Inc. is positioning itself to supply the emerging demand for high-potential mushrooms dietary elixirs as wellness products that combat stress, enhance immunity against disease and increase mental clarity Market analysts predict the overall functional foods industry will reach revenues of $268 billion by 2027, and that the functional mushroom segment will grow at a CAGR of 8.04 percent by 2024 as part of the trend Rritual was recently certified by the USDA as an organic product, providing third-party validation Rritual’s quality protocols Rritual’s initial product launch includes elixirs containing mushroom and adaptogenic herb blends such as Chaga-Eleuthero, Lion’s…

MondayNov 30, 2020 12:00 pm

Speakers at Harvard Law School Webinar Voice Support for Psychedelics Decriminalization

In a webinar hosted by the Petrie-Flom Center for Health Law Policy of the Harvard Law School, speakers championed for psychedelics decriminalization. The webinar, which gathered more than 200 individuals, had panelists who discussed the benefits of the decriminalization of psychedelics while debating on the history and safety of the substances and how they affected people of color. The webinar’s moderator, Mason Marks, is a law professor at Gonzaga University. The speakers featured on the webinar included Patricia J. Zettler, associate professor at the Ohio State Moritz College of Law; Ifetayo Harvey, founder of the People of Color Psychedelic Collective;…

WednesdayNov 25, 2020 12:30 pm

Rritual Superfoods’ Extensive Distribution Network Set to Take Functional Mushrooms Mainstream

Functional Mushrooms Market Set for CAGR of 5.6% Expected to Reach $24.85 billion by 2026 Rritual Superfoods Has Launched Three Mushroom-based Products Products Boost Immune System, Brain Power and Relieve Stress Company’s Extensive Distribution Network Set to Accelerate Sales Consumers today shop for food with a number of considerations in mind, including food safety and the health benefits of their selected grocery items. This has resulted in increased demand for functional foods, with one sector — functional mushrooms — projected to increase at a CAGR of 5.6% during 2021–2026. This would put the market for functional mushrooms at $24.85 billion…

WednesdayNov 25, 2020 11:15 am

Canadian Government Gives Formal Response to Petition to Decriminalize Psychedelics

Officials of the federal government of Canada have given an official response to a petition that called for psychedelic decriminalization in the country. The statement highlighted that there were various ways for some individuals to obtain exemptions to consume the substances legally, despite the drugs being illegal for the Canadian majority. Government ministers stated that the psychedelic substances had to be studied more before any reforms were made. The petition, which garnered almost 15,000 signatures, was launched on the House of Commons’ site earlier this summer. The appeal requested legislators to decriminalize entheogenic fungi and plants to be used in…

TuesdayNov 24, 2020 3:00 pm

Want to Invest in the Psychedelics Market? Here’s a Few Important Aspects to Consider

A few weeks ago, Psychedelic Capital held an event online that discussed various ways to carry out one’s due diligence with regard to investing in psychedelics. The discussion was hosted by Richard Skaife, a partner in the investment group Conscious Fund. The experts on the panel included Zuber Lawler, partner; Jayashree Mitra, BDO Capital Advisors director of acquisitions and mergers; Michael Astone; and Ambria Capital director, Cody Shandraw. We have seen the psychedelics market grow as more and more research comes to light regarding the various benefits these substances have, with the potential for many more discoveries. This particular sector…

MondayNov 23, 2020 2:30 pm

Psilocybin Decriminalization Bill Passed in New Jersey

A New Jersey lawmakers’ committee recently voted to progress a measure that would decriminalize cannabis possession and decrease the punishments for possessing psilocybin mushrooms in small amounts. This action, undertaken by the state’s Appropriations and Senate Budget Committee, took place days after voters from New Jersey approved a constitutional amendment that would create a regulated recreational cannabis market in the state while also legalizing marijuana for adults. This action, S. 2535, which had been launched in June, would eliminate criminal punishment for the possession of as much as six cannabis ounces. Chris Goldstein, the South Jersey spokesman for the National…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000